AMRX logo

Amneal Pharmaceuticals (AMRX) Operating profit

annual operating profit:

$296.76M+$75.64M(+34.21%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AMRX annual operating income is $296.76 million, with the most recent change of +$75.64 million (+34.21%) on December 31, 2024.
  • During the last 3 years, AMRX annual operating profit has risen by +$102.86 million (+53.04%).
  • AMRX annual operating profit is now at all-time high.

Performance

AMRX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

quarterly operating profit:

$100.92M+$22.85M(+29.27%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX quarterly operating income is $100.92 million, with the most recent change of +$22.85 million (+29.27%) on March 31, 2025.
  • Over the past year, AMRX quarterly operating profit has increased by +$15.73 million (+18.47%).
  • AMRX quarterly operating profit is now at all-time high.

Performance

AMRX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM operating profit:

$363.18M+$15.73M(+4.53%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX TTM operating income is $363.18 million, with the most recent change of +$15.73 million (+4.53%) on March 31, 2025.
  • Over the past year, AMRX TTM operating profit has increased by +$90.72 million (+33.30%).
  • AMRX TTM operating profit is now at all-time high.

Performance

AMRX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

AMRX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.2%+18.5%+33.3%
3 y3 years+53.0%+351.7%+117.2%
5 y5 years+313.7%+48.7%+3221.7%

AMRX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+57.6%at high+351.7%at high+171.7%
5 y5-yearat high+313.7%at high+2547.4%at high+3221.7%
alltimeall timeat high+313.7%at high+269.9%at high+361.5%

AMRX Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$100.92M(+29.3%)
$363.18M(+4.5%)
Dec 2024
$296.76M(+34.2%)
$78.07M(-11.1%)
$347.44M(+14.4%)
Sep 2024
-
$87.80M(-8.9%)
$303.63M(+3.6%)
Jun 2024
-
$96.39M(+13.2%)
$293.02M(+7.5%)
Mar 2024
-
$85.18M(+148.6%)
$272.45M(+21.5%)
Dec 2023
$221.13M(+17.4%)
$34.26M(-55.6%)
$224.25M(-14.2%)
Sep 2023
-
$77.19M(+1.8%)
$261.42M(+14.6%)
Jun 2023
-
$75.82M(+105.0%)
$228.06M(+12.0%)
Mar 2023
-
$36.98M(-48.2%)
$203.56M(+7.7%)
Dec 2022
$188.29M(-2.9%)
$71.43M(+63.0%)
$188.92M(+41.3%)
Sep 2022
-
$43.83M(-14.6%)
$133.66M(-8.7%)
Jun 2022
-
$51.32M(+129.7%)
$146.38M(-12.4%)
Mar 2022
-
$22.34M(+38.3%)
$167.18M(-13.8%)
Dec 2021
$193.91M
$16.16M(-71.4%)
$193.91M(-4.5%)
Sep 2021
-
$56.56M(-21.6%)
$202.97M(+35.1%)
Jun 2021
-
$72.11M(+47.0%)
$150.22M(+62.8%)
DateAnnualQuarterlyTTM
Mar 2021
-
$49.07M(+94.5%)
$92.28M(-16.9%)
Dec 2020
$111.08M(-180.0%)
$25.22M(+561.7%)
$111.08M(+61.0%)
Sep 2020
-
$3.81M(-73.1%)
$68.98M(+357.0%)
Jun 2020
-
$14.17M(-79.1%)
$15.10M(-229.8%)
Mar 2020
-
$67.87M(-502.2%)
-$11.63M(-91.6%)
Dec 2019
-$138.89M(-149.9%)
-$16.88M(-66.3%)
-$138.89M(+130.0%)
Sep 2019
-
-$50.07M(+298.7%)
-$60.38M(-189.4%)
Jun 2019
-
-$12.56M(-78.8%)
$67.57M(-54.4%)
Mar 2019
-
-$59.38M(-196.3%)
$148.04M(-46.8%)
Dec 2018
$278.11M(+23.5%)
$61.64M(-20.8%)
$278.11M(-5.6%)
Sep 2018
-
$77.87M(+14.7%)
$294.69M(+6.6%)
Jun 2018
-
$67.91M(-3.9%)
$276.38M(+9.2%)
Mar 2018
-
$70.69M(-9.6%)
$253.16M(+38.7%)
Dec 2017
$225.19M(-17.8%)
$78.22M(+31.3%)
$182.47M(+75.0%)
Sep 2017
-
$59.56M(+33.3%)
$104.24M(+133.3%)
Jun 2017
-
$44.69M
$44.69M
Dec 2016
$273.95M
-
-

FAQ

  • What is Amneal Pharmaceuticals annual operating income?
  • What is the all time high annual operating profit for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual operating profit year-on-year change?
  • What is Amneal Pharmaceuticals quarterly operating income?
  • What is the all time high quarterly operating profit for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly operating profit year-on-year change?
  • What is Amneal Pharmaceuticals TTM operating income?
  • What is the all time high TTM operating profit for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals TTM operating profit year-on-year change?

What is Amneal Pharmaceuticals annual operating income?

The current annual operating profit of AMRX is $296.76M

What is the all time high annual operating profit for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual operating income is $296.76M

What is Amneal Pharmaceuticals annual operating profit year-on-year change?

Over the past year, AMRX annual operating income has changed by +$75.64M (+34.21%)

What is Amneal Pharmaceuticals quarterly operating income?

The current quarterly operating profit of AMRX is $100.92M

What is the all time high quarterly operating profit for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly operating income is $100.92M

What is Amneal Pharmaceuticals quarterly operating profit year-on-year change?

Over the past year, AMRX quarterly operating income has changed by +$15.73M (+18.47%)

What is Amneal Pharmaceuticals TTM operating income?

The current TTM operating profit of AMRX is $363.18M

What is the all time high TTM operating profit for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high TTM operating income is $363.18M

What is Amneal Pharmaceuticals TTM operating profit year-on-year change?

Over the past year, AMRX TTM operating income has changed by +$90.72M (+33.30%)
On this page